Dan Roden
Faculty Member
Last active: 3/24/2020

Merging Electronic Health Record Data and Genomics for Cardiovascular Research: A Science Advisory From the American Heart Association.

Hall JL, Ryan JJ, Bray BE, Brown C, Lanfear D, Newby LK, Relling MV, Risch NJ, Roden DM, Shaw SY, Tcheng JE, Tenenbaum J, Wang TN, Weintraub WS, American Heart Association Professional and Public Education and Publications Committee of the Council on Functional Genomics and Translational Biology, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Quality of Care and Outcomes Research, and Stroke Council
Circ Cardiovasc Genet. 2016 9 (2): 193-202

PMID: 26976545 · PMCID: PMC5646218 · DOI:10.1161/HCG.0000000000000029

The process of scientific discovery is rapidly evolving. The funding climate has influenced a favorable shift in scientific discovery toward the use of existing resources such as the electronic health record. The electronic health record enables long-term outlooks on human health and disease, in conjunction with multidimensional phenotypes that include laboratory data, images, vital signs, and other clinical information. Initial work has confirmed the utility of the electronic health record for understanding mechanisms and patterns of variability in disease susceptibility, disease evolution, and drug responses. The addition of biobanks and genomic data to the information contained in the electronic health record has been demonstrated. The purpose of this statement is to discuss the current challenges in and the potential for merging electronic health record data and genomics for cardiovascular research.

© 2016 American Heart Association, Inc.

MeSH Terms (10)

Biomedical Research Cardiovascular Diseases Data Collection Electronic Health Records Genomics Genomics Humans Informed Consent Patient Care Societies, Medical

Connections (1)

This publication is referenced by other Labnodes entities: